Abstract:Background: Substantial evidence suggests that cognitive deficits might persist after remission of a major depressive episode. However, results are inconsistent relative to the importance, pattern, severity, and moderating factors of this impairment. We aimed to determine how cognitive function following a major depressive episode compares with normal function, to specify the pattern and severity of persistent cognitive dysfunctions, and to examine the potential moderator effect of ten prespecified clinical and demographic variables. Methods: We did a systematic review and meta-analysis of the published research. We searched systematically MEDLINE, Embase, PsycARTICLES, PsycINFO, the Cochrane Library, and relevant reviews identified by our database search, for research published from Jan 1, 1972, up to Jan 31, 2018, for studies of patients with past depression. We included all independent studies of patients who were assessed while in remission from a major depressive episode with at least one cognitive test, with inclusion of a healthy control group assessed with either the same test(s) as the major depressive episode group or with a standardised test with published age-stratified normative data. The main outcome was the difference in cognitive performance between major depressive episode remitters and healthy controls. Effect sizes were calculated using random-effects models for cognitive outcomes classified into 18 standard domains. Moderators of between-study variability were assessed using mixed-effects subgroup analyses and meta-regressions. Findings: Of 10 126 citations identified by our search, 75 cognitive variables from 252 eligible studies (11 882 major depressive episode remitters and 8533 healthy controls) were included in our meta-analysis. Significant deficits following major depressive episode remission were observed in 55 (73%) of the 75 cognitive variables. These deficits (in the domains of processing speed, visual selective attention, working memory, verbal learning, and executive functioning), were generally small (30 [40%] of the 75 variables) or medium (22 [29%]) in size, although three long-term memory variables showed large deficits: g=-0·81 [95% CI -1·01 to -0·61] for logical memory immediate recall, g=-0·88 [-1·19 to -0·57] for logical memory delayed recall, and g=-0·84 [-1·18 to -0·50] for Cambridge Neuropsychological Test Automated Battery pattern recognition latency. Auditory attention, general autobiographical memory, inhibition ability unconstrained by speed, and intellectual functioning unconstrained by speed were equivalent between major depressive episode remitters and matched controls. The number of previous depressive episodes explained heterogeneity in the majority of variables (z=-2·06 [p=0·039] to z=-4·26 [p<0·0001]). Interpretation: Deficits in selective attention, working memory, and long-term memory persist in remission from a major depressive episode and worsen with repeated episodes. Depression treatments, including relapse prevention, need to target these cognitive functions to optimise prognosis. Funding: None.

Comparison of Residual Depressive Symptoms and Functional Impairment Between Fully and Partially Remitted Patients with Major Depressive Disorder: a Multicenter Study.

The residual physical symptoms in Chinese patients with major depressive disorder after acute treatment phase: a cross-sectional survey among eleven mental health centers

The Impacts of Anhedonia on Brain Functional Alterations in Patients with Major Depressive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study of Regional Homogeneity.

A National Survey of Residual Symptoms in Chinese Depressive Patients after Acute Phase Treatment

Association between residual symptoms and social functioning in patients with depression.

Identifying the core residual symptom in patients with major depressive disorder using network analysis and illustrating its association with prognosis: A study based on the national cohorts in China

Relationship between cognitive function and functional outcomes in remitted major depression

Restoration of psychosocial functioning in remitted major depressive disorder patients: A 1-year longitudinal study

Acute treatment residual depression symptoms and functional impairment among depressive patients of different age groups and education levels in China: A prospective, multicenter, randomized study

Meta‐Analysis of Brain Volumetric Abnormalities in Patients with Remitted Major Depressive Disorder

[Screening of orthopaedic abnormalities of infant].

Sports injury research.

Reduced Nucleus Accumbens Functional Connectivity in Reward Network and Default Mode Network in Patients with Recurrent Major Depressive Disorder.

Some software issues of strategic defense systems

Rapid camp-phosphodiesterase activation by parathyroid hormone in umr-106 rat osteoblast-like cells’

Cognitive function following a major depressive episode: a systematic review and meta-analysis

A study on cognitive impairment during depression remission stage

State-Independent Microstructural White Matter Abnormalities in Major Depressive Disorder.

Exploration of Major Cognitive Deficits in Medication-Free Patients with Major Depressive Disorder

Aberrant Resting-State Functional Connectivity in MDD and the Antidepressant Treatment Effect—A 6-Month Follow-Up Study

Psychosocial functioning and its influencing factors in patients with depression post-remission: Implications for assessment and interventions